 David Brumbaugh
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medical Marijuana | 2 | 2021 | 122 | 1.120 |
Why?
| | Foreign Bodies | 5 | 2020 | 110 | 0.980 |
Why?
| | Esophagus | 4 | 2018 | 262 | 0.790 |
Why?
| | Advisory Committees | 2 | 2020 | 229 | 0.700 |
Why?
| | Clostridium Infections | 2 | 2023 | 74 | 0.670 |
Why?
| | Muscular Dystrophy, Duchenne | 2 | 2018 | 93 | 0.640 |
Why?
| | Fatty Liver | 2 | 2013 | 253 | 0.640 |
Why?
| | Organizational Policy | 1 | 2020 | 78 | 0.610 |
Why?
| | Specialties, Surgical | 1 | 2020 | 82 | 0.600 |
Why?
| | Fecal Microbiota Transplantation | 2 | 2023 | 27 | 0.570 |
Why?
| | Esophagoscopy | 2 | 2018 | 223 | 0.570 |
Why?
| | Nutrition Disorders | 1 | 2018 | 20 | 0.570 |
Why?
| | Electric Power Supplies | 4 | 2020 | 47 | 0.560 |
Why?
| | Dilatation | 1 | 2018 | 73 | 0.550 |
Why?
| | Esophageal Stenosis | 1 | 2018 | 60 | 0.540 |
Why?
| | Fluoroscopy | 1 | 2018 | 180 | 0.540 |
Why?
| | Epidermolysis Bullosa | 1 | 2018 | 69 | 0.530 |
Why?
| | Hospitals, Pediatric | 2 | 2021 | 558 | 0.520 |
Why?
| | Feces | 2 | 2017 | 496 | 0.490 |
Why?
| | Diarrhea | 1 | 2017 | 193 | 0.480 |
Why?
| | Pharynx | 1 | 2016 | 59 | 0.480 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 222 | 0.470 |
Why?
| | Intestines | 2 | 2016 | 354 | 0.470 |
Why?
| | Surgeons | 1 | 2020 | 340 | 0.460 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 160 | 0.440 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2016 | 237 | 0.410 |
Why?
| | Informed Consent | 1 | 2016 | 199 | 0.410 |
Why?
| | Gastroenterology | 1 | 2016 | 191 | 0.380 |
Why?
| | Gastrointestinal Hemorrhage | 2 | 2011 | 138 | 0.370 |
Why?
| | Hyperbilirubinemia | 1 | 2012 | 11 | 0.370 |
Why?
| | Muscle Cells | 1 | 2012 | 41 | 0.350 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2013 | 178 | 0.350 |
Why?
| | Diabetes, Gestational | 2 | 2012 | 306 | 0.350 |
Why?
| | Microbiota | 2 | 2016 | 730 | 0.340 |
Why?
| | Intra-Abdominal Fat | 1 | 2012 | 101 | 0.330 |
Why?
| | Esophageal Diseases | 1 | 2011 | 30 | 0.330 |
Why?
| | Adiposity | 2 | 2012 | 532 | 0.320 |
Why?
| | Child | 12 | 2023 | 22740 | 0.310 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 627 | 0.310 |
Why?
| | Obesity | 2 | 2013 | 3118 | 0.300 |
Why?
| | Infant | 7 | 2020 | 10091 | 0.280 |
Why?
| | Lipid Metabolism | 1 | 2012 | 529 | 0.280 |
Why?
| | Energy Metabolism | 1 | 2013 | 935 | 0.260 |
Why?
| | Pediatrics | 1 | 2016 | 1125 | 0.260 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2013 | 655 | 0.250 |
Why?
| | Hemorrhage | 1 | 2011 | 822 | 0.230 |
Why?
| | Child, Preschool | 9 | 2020 | 11868 | 0.220 |
Why?
| | Neoplasms | 1 | 2021 | 2913 | 0.220 |
Why?
| | Liver | 1 | 2013 | 1899 | 0.220 |
Why?
| | Humans | 25 | 2023 | 145783 | 0.200 |
Why?
| | Esophageal Fistula | 2 | 2016 | 21 | 0.200 |
Why?
| | Vascular Fistula | 2 | 2016 | 22 | 0.200 |
Why?
| | Insulin Resistance | 1 | 2012 | 1244 | 0.200 |
Why?
| | Mineral Oil | 1 | 2002 | 2 | 0.180 |
Why?
| | Pneumonia, Aspiration | 1 | 2002 | 16 | 0.180 |
Why?
| | Brain Abscess | 1 | 2021 | 10 | 0.180 |
Why?
| | Adolescent | 6 | 2023 | 22577 | 0.170 |
Why?
| | Federal Government | 1 | 2020 | 23 | 0.160 |
Why?
| | Retrospective Studies | 5 | 2023 | 17330 | 0.160 |
Why?
| | Diagnostic Errors | 1 | 2021 | 178 | 0.160 |
Why?
| | State Government | 1 | 2020 | 46 | 0.160 |
Why?
| | Parents | 2 | 2021 | 1407 | 0.150 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3916 | 0.150 |
Why?
| | Legislation, Drug | 1 | 2020 | 73 | 0.150 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2191 | 0.150 |
Why?
| | Morbidity | 1 | 2020 | 322 | 0.150 |
Why?
| | Recurrence | 3 | 2023 | 1139 | 0.150 |
Why?
| | Single-Balloon Enteroscopy | 1 | 2018 | 4 | 0.140 |
Why?
| | Female | 12 | 2020 | 79045 | 0.140 |
Why?
| | Magnets | 1 | 2018 | 21 | 0.140 |
Why?
| | Nutritional Requirements | 1 | 2018 | 78 | 0.140 |
Why?
| | Body Composition | 2 | 2012 | 693 | 0.140 |
Why?
| | Pregnancy | 4 | 2016 | 7216 | 0.130 |
Why?
| | Endocrine System | 1 | 2018 | 22 | 0.130 |
Why?
| | Patient Safety | 1 | 2021 | 356 | 0.130 |
Why?
| | Infant, Newborn | 3 | 2016 | 6465 | 0.130 |
Why?
| | Treatment Outcome | 5 | 2023 | 11794 | 0.130 |
Why?
| | Medical Oncology | 1 | 2021 | 340 | 0.130 |
Why?
| | Neuromuscular Junction | 1 | 2018 | 65 | 0.130 |
Why?
| | Male | 11 | 2021 | 73011 | 0.130 |
Why?
| | Intestine, Small | 1 | 2018 | 167 | 0.130 |
Why?
| | Stomach | 1 | 2017 | 111 | 0.130 |
Why?
| | Intubation, Gastrointestinal | 1 | 2017 | 81 | 0.130 |
Why?
| | Gastrostomy | 1 | 2017 | 130 | 0.120 |
Why?
| | Nutritional Status | 1 | 2018 | 353 | 0.120 |
Why?
| | Disclosure | 1 | 2016 | 84 | 0.110 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 204 | 0.110 |
Why?
| | Down Syndrome | 1 | 2002 | 525 | 0.110 |
Why?
| | Rectum | 1 | 2016 | 182 | 0.110 |
Why?
| | Colonoscopy | 1 | 2017 | 264 | 0.110 |
Why?
| | Quality Improvement | 2 | 2020 | 1296 | 0.110 |
Why?
| | Cohort Studies | 2 | 2017 | 6033 | 0.100 |
Why?
| | Risk Factors | 3 | 2013 | 10919 | 0.100 |
Why?
| | Vagina | 1 | 2016 | 203 | 0.100 |
Why?
| | Referral and Consultation | 1 | 2020 | 869 | 0.100 |
Why?
| | Disease Management | 1 | 2018 | 653 | 0.100 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 778 | 0.100 |
Why?
| | Colorado | 2 | 2020 | 4556 | 0.100 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1197 | 0.100 |
Why?
| | Cholestasis, Extrahepatic | 1 | 2012 | 3 | 0.090 |
Why?
| | Hepatolenticular Degeneration | 1 | 2012 | 15 | 0.090 |
Why?
| | Choledochal Cyst | 1 | 2012 | 17 | 0.090 |
Why?
| | Young Adult | 2 | 2020 | 14254 | 0.090 |
Why?
| | Biliary Tract Diseases | 1 | 2012 | 33 | 0.090 |
Why?
| | Hepatitis A | 1 | 2012 | 25 | 0.090 |
Why?
| | Gallstones | 1 | 2012 | 35 | 0.090 |
Why?
| | Alagille Syndrome | 1 | 2012 | 29 | 0.090 |
Why?
| | Aspartate Aminotransferases | 1 | 2012 | 85 | 0.090 |
Why?
| | Bilirubin | 1 | 2012 | 99 | 0.090 |
Why?
| | Intracellular Space | 1 | 2012 | 64 | 0.090 |
Why?
| | Alanine Transaminase | 1 | 2012 | 151 | 0.090 |
Why?
| | Skin | 1 | 2016 | 754 | 0.090 |
Why?
| | Puberty | 1 | 2012 | 137 | 0.080 |
Why?
| | Biliary Atresia | 1 | 2012 | 158 | 0.080 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2013 | 265 | 0.080 |
Why?
| | Neonatal Screening | 1 | 2012 | 179 | 0.080 |
Why?
| | Jejunal Diseases | 1 | 2009 | 7 | 0.070 |
Why?
| | Capsule Endoscopy | 1 | 2009 | 25 | 0.070 |
Why?
| | Trachea | 1 | 2011 | 258 | 0.070 |
Why?
| | Liver Diseases | 1 | 2012 | 305 | 0.070 |
Why?
| | Epigenesis, Genetic | 1 | 2013 | 693 | 0.070 |
Why?
| | Metformin | 1 | 2012 | 329 | 0.070 |
Why?
| | Decision Making | 1 | 2016 | 982 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 469 | 0.070 |
Why?
| | Aorta | 1 | 2011 | 441 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1512 | 0.070 |
Why?
| | Phenotype | 1 | 2013 | 3170 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2399 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2012 | 3418 | 0.050 |
Why?
| | Age Factors | 1 | 2012 | 3346 | 0.050 |
Why?
| | Adult | 3 | 2023 | 40881 | 0.050 |
Why?
| | Prospective Studies | 1 | 2016 | 8078 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2011 | 1582 | 0.050 |
Why?
| | Bronchoalveolar Lavage | 1 | 2002 | 89 | 0.040 |
Why?
| | Headache Disorders, Secondary | 1 | 2021 | 4 | 0.040 |
Why?
| | Neurologic Examination | 1 | 2021 | 132 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2021 | 2770 | 0.040 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2001 | 49 | 0.040 |
Why?
| | Reoviridae | 1 | 2001 | 38 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2021 | 305 | 0.040 |
Why?
| | Endopeptidases | 1 | 2001 | 80 | 0.040 |
Why?
| | Constipation | 1 | 2002 | 98 | 0.040 |
Why?
| | Family Health | 1 | 2021 | 191 | 0.040 |
Why?
| | X Chromosome | 1 | 2000 | 66 | 0.040 |
Why?
| | Prednisone | 1 | 2021 | 226 | 0.040 |
Why?
| | Capsid | 1 | 2001 | 94 | 0.040 |
Why?
| | Agammaglobulinemia | 1 | 2000 | 36 | 0.040 |
Why?
| | Leucine | 1 | 2001 | 116 | 0.040 |
Why?
| | Biomarkers | 1 | 2012 | 4302 | 0.040 |
Why?
| | Sucralfate | 1 | 2020 | 5 | 0.040 |
Why?
| | Capsid Proteins | 1 | 2001 | 94 | 0.040 |
Why?
| | Migraine Disorders | 1 | 2021 | 114 | 0.040 |
Why?
| | Deglutition | 1 | 2020 | 73 | 0.040 |
Why?
| | Pneumococcal Infections | 1 | 2000 | 104 | 0.040 |
Why?
| | Arthritis, Infectious | 1 | 2000 | 76 | 0.040 |
Why?
| | Critical Pathways | 1 | 2020 | 111 | 0.040 |
Why?
| | Information Dissemination | 1 | 2020 | 224 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2020 | 276 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 403 | 0.030 |
Why?
| | Nutrition Therapy | 1 | 2018 | 37 | 0.030 |
Why?
| | Eating | 1 | 2020 | 387 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2021 | 532 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2001 | 447 | 0.030 |
Why?
| | Program Evaluation | 1 | 2020 | 944 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2016 | 251 | 0.020 |
Why?
| | Animals | 2 | 2013 | 38102 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1711 | 0.020 |
Why?
| | Time Factors | 1 | 2002 | 7134 | 0.020 |
Why?
| | Patient Care Team | 1 | 2016 | 697 | 0.020 |
Why?
| | Prednisolone | 1 | 2009 | 67 | 0.020 |
Why?
| | Algorithms | 1 | 2016 | 1851 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 675 | 0.010 |
Why?
| | Cathepsin L | 1 | 2001 | 9 | 0.010 |
Why?
| | Cathepsin D | 1 | 2001 | 22 | 0.010 |
Why?
| | Cathepsins | 1 | 2001 | 24 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2001 | 78 | 0.010 |
Why?
| | Virus Assembly | 1 | 2001 | 82 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2000 | 273 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2001 | 563 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2009 | 5428 | 0.010 |
Why?
| | Risk Assessment | 1 | 2009 | 3752 | 0.010 |
Why?
| | Streptococcus pneumoniae | 1 | 2000 | 186 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2001 | 560 | 0.010 |
Why?
| | Knee Joint | 1 | 2000 | 429 | 0.010 |
Why?
| | Mutation | 1 | 2001 | 4090 | 0.000 |
Why?
| | Mice | 1 | 2001 | 18356 | 0.000 |
Why?
|
|
Brumbaugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|